Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection

Suleyman Kugu1 Lutfi Kırdar Kartal Training and Research Hospital, Eye Clinic, Istanbul

Mehmet Sahin Sevim2 Haydarpasa Numune Training and Research Hospital, Eye Clinic, Istanbul

Nilufer Zorlutuna Kaymak1 Lutfi Kırdar Kartal Training and Research Hospital, Eye Clinic, IstanbulCorrespondence[email protected]

Gurkan Erdogan3 Umraniye Training and Research Hospital, Eye Clinic, Istanbul

Baran Kandemir1 Lutfi Kırdar Kartal Training and Research Hospital, Eye Clinic, Istanbul

Omer Kamil Dogan4 World Eye Hospital, Eye Clinic, Istanbul, Turkey

Abstract

We report a case of group G Streptococcus endophthalmitis following an intravitreal ranibizumab injection for a choroidal neovascular membrane. Pars plana vitrectomy was applied for endophthalmitis and group G Streptococcus cultures were isolated in the vitreous samples taken from the patient. Twenty-four hours following pars plana vitrectomy the patient underwent myocardial infarction and cardiac arrest. To our knowledge this is the first reported case of group G Streptococcus endophthalmitis following an intravitreal injection.

Keywords:

Disclosure

The authors report no conflicts of interest in this work.

Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection

Information for

Open access

Opportunities

Help and information

Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection

Abstract

Disclosure

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature